Please click this link to refresh if your video doesn't automatically restart after 60 seconds.
This session will focus on reviewing the clinical efficacy and safety data from a Phase 2 and 3 investigational program for the treatment of post-traumatic stress disorder (PTSD) in adults and briefly cover key aspects of PTSD.